PTC Therapeutics's market cap is currently ―. The company's EPS TTM is $-8.373; its P/E ratio is -2.95; PTC Therapeutics is scheduled to report earnings on April 25, 2024, and the estimated EPS forecast is $-1.28. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 196.58M	$ 174.59M	$ 220.38M	$ 167.41M	$ 217.13M
Gross Profit	$ 196.58M	$ 213.81M	$ 220.38M	$ 167.41M	$ 203.12M
EBIT	$ -166.59M	$ -237.48M	$ -107.66M	$ -165.19M	$ -106.33M
EBITDA	$ -101.48M	$ -183.18M	$ -68.24M	-	$ -71.85M
Net Income Common Stockholders	$ -113.98M	$ -198.88M	$ -138.96M	$ -170.89M	$ -109.31M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 294.81M	$ 337.94M	$ 286.30M	$ 410.70M	$ 288.43M
Total Assets	$ 1.26B	$ 1.34B	$ 1.61B	$ 1.71B	$ 1.58B
Total Debt	$ 704.35M	$ 702.68M	$ 701.17M	$ 703.65M	$ 415.03M
Net Debt	$ 409.54M	$ 364.74M	$ 414.87M	$ 292.95M	$ 126.59M
Total Liabilities	$ 1.93B	$ 1.92B	$ 2.07B	$ 1.71B	$ 1.80B
Stockholders Equity	$ -670.82M	$ -579.25M	$ -457.56M	$ -347.11M	$ -226.90M
Cash Flow	-
Free Cash Flow	$ -45.23M	$ 95.50M	$ -75.56M	$ -199.25M	$ -64.07M
Operating Cash Flow	$ -16.02M	$ 114.78M	$ -31.89M	$ -172.25M	$ -38.05M
Investing Cash Flow	$ -28.10M	$ -152.65M	$ -26.57M	$ 38.74M	$ 136.44M
Financing Cash Flow	$ 3.36M	$ 18.46M	$ 4.09M	$ 302.92M	$ -140.00M

Currency in USD

PTC Therapeutics Earnings and Revenue History

Income Statement >

PTC Therapeutics Debt to Assets

Balance Sheet >

PTC Therapeutics Cash Flow

Cash Flow >

PTC Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing